BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

757 related articles for article (PubMed ID: 12052325)

  • 1. Leukotrienes in respiratory disease.
    McMillan RM
    Paediatr Respir Rev; 2001 Sep; 2(3):238-44. PubMed ID: 12052325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of 5-lipoxygenase inhibitors and leukotriene receptor antagonists in the treatment of chronic asthma.
    Sorkness CA
    Pharmacotherapy; 1997; 17(1 Pt 2):50S-54S. PubMed ID: 9017788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [New developments in asthma therapy: how do individual leukotriene antagonists work?].
    Wagener M
    Praxis (Bern 1994); 1998 Feb; 87(8):271-5. PubMed ID: 9542455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The use of leukotriene receptor antagonists and 5-lipoxygenase inhibitors in bronchial asthma treatment].
    Kuziemski K; Mincewicz G; Sopel R; Słomiński JM
    Pol Merkur Lekarski; 1998 Dec; 5(30):317-20. PubMed ID: 10101512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacology of leukotriene receptor antagonists and 5-lipoxygenase inhibitors in the management of asthma.
    Drazen JM
    Pharmacotherapy; 1997; 17(1 Pt 2):22S-30S. PubMed ID: 9017785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The anti-leukotrienes: their use in asthma].
    Devillier P; Millart H; Advenier C
    Rev Med Brux; 1997 Sep; 18(4):279-85. PubMed ID: 9411661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The role of leukotrienes in inflammation and leukotriene inhibitors].
    Kupczyk M; Kuna P
    Pol Merkur Lekarski; 1999 Sep; 7(39):85-93. PubMed ID: 10598480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of asthma with drugs modifying the leukotriene pathway.
    Drazen JM; Israel E; O'Byrne PM
    N Engl J Med; 1999 Jan; 340(3):197-206. PubMed ID: 9895400
    [No Abstract]   [Full Text] [Related]  

  • 9. [Status of leukotrienes in the pathophysiology of asthma. Necessity for antileukotrienes treatment].
    Fal AM; Kopeć A
    Pneumonol Alergol Pol; 2010; 78(1):68-73. PubMed ID: 20162521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New perspectives for asthma treatment: anti-leukotriene drugs.
    García-Marcos L; Schuster A
    Pediatr Allergy Immunol; 1999 May; 10(2):77-88. PubMed ID: 10478608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leukotrienes, leukotriene receptor antagonists and leukotriene synthesis inhibitors in asthma: an update. Part I: synthesis, receptors and role of leukotrienes in asthma.
    Devillier P; Baccard N; Advenier C
    Pharmacol Res; 1999 Jul; 40(1):3-13. PubMed ID: 10378985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of leukotriene receptor antagonists and synthesis inhibitors in asthma.
    O'Byrne PM; Gauvreau GM; Murphy DM
    J Allergy Clin Immunol; 2009 Sep; 124(3):397-403. PubMed ID: 19608262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leukotriene synthesis inhibitors versus antagonists: the pros and cons.
    Steinke JW; Culp JA
    Curr Allergy Asthma Rep; 2007 May; 7(2):126-33. PubMed ID: 17437683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Leukotriene antagonists: a new approach in the treatment of asthma].
    Devillier P; Bessard G; Advenier C
    Rev Mal Respir; 1997 Jun; 14(3):159-70. PubMed ID: 9411593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Novel treatment of bronchial asthma: application of leukotriene receptor antagonists and leukotriene synthesis inhibitors].
    Diamant Z; Sterk PJ
    Ned Tijdschr Geneeskd; 1998 Jan; 142(5):72-8. PubMed ID: 12013053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipoxygenase inhibitors from natural plant sources. Part 2: medicinal plants with inhibitory activity on arachidonate 12-lipoxygenase, 15-lipoxygenase and leukotriene receptor antagonists.
    Schneider I; Bucar F
    Phytother Res; 2005 Apr; 19(4):263-72. PubMed ID: 16041764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New frontiers in asthma therapy: leukotriene receptor antagonists and 5-lipoxygenase inhibitors. Introduction.
    Hendeles L
    Pharmacotherapy; 1997; 17(1 Pt 2):1S-2S. PubMed ID: 9017782
    [No Abstract]   [Full Text] [Related]  

  • 18. Pathophysiology of the cysteinyl leukotrienes and effects of leukotriene receptor antagonists in asthma.
    Bisgaard H
    Allergy; 2001; 56 Suppl 66():7-11. PubMed ID: 11421935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leukotrienes, leukotriene receptor antagonists and leukotriene synthesis inhibitors in asthma: an update. Part II: clinical studies with leukotriene receptor antagonists and leukotriene synthesis inhibitors in asthma.
    Devillier P; Baccard N; Advenier C
    Pharmacol Res; 1999 Jul; 40(1):15-29. PubMed ID: 10378986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Leukotriene receptor antagonists and bronchial asthma].
    Jäger L; Kroegel C
    Arzneimittelforschung; 1998 Mar; 48(3):205-11. PubMed ID: 9553675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.